Latest Interviews
"As more robust drug candidates are emerging, I am willing to bet that we will have the first NASH drug approved in 2023."
59972
"We are looking into new ways to reap the benefits of artificial intelligence, particularly on the clinical side. On the physical side, Meteoric Biopharmaceuticals will have a new factory and lab up and running by the end of 2024, that will work on advanced fermentation processes."
59970
"We now offer end-to-end modular technical services, encompassing both pre-clinical and clinical development of biosimilars addressing global regulatory requirements."
59968
"The whole point of our work in the country is to empower Congolese people and give them a sense of achievement. AMS only hires locally."
59966
"I strongly believe Kibi has room to grow into a multi-million oz deposit and become the next big discovery in Ghana."
59964
"Advanced data analysis is a huge growth area, and we are overloaded with opportunities for our team to address issues to optimize operations at the study and operational stages."